| Patent application number | Description | Published |
|---|
| 20080224102 | Black conductive thick film compositions, black electrodes, and methods of forming thereof - This invention is directed to black conductive compositions, black electrodes made from such compositions and methods of forming such electrodes. In particular, the invention is directed to a single layer bus electrode. | 09-18-2008 |
| 20090004390 | Black pigment compositions, thick film black pigment compositions, conductive single layer thick film compositions, and black and conductive electrodes formed therefrom - The present invention is directed to pigment compositions, thick film black pigment compositions, conductive single layer thick film compositions, black electrodes made from such black conductive compositions and methods of forming such electrodes, and to the uses of such compositions, electrodes, and methods in flat panel display applications, including alternating-current plasma display panel devices (AC PDP). | 01-01-2009 |
| 20090208658 | Black Pigment Compositions, Thick Film Black Pigment Compositions, Conductive Single Layer Thick Film Compositions, and Black and Conductive Electrodes Formed Therefrom - The present invention is directed to pigment compositions, thick film black pigment compositions, conductive single layer thick film compositions, black electrodes made from such black conductive compositions and methods of forming such electrodes, and to the uses of such compositions, electrodes, and methods in flat panel display applications, including alternating-current plasma display panel devices (AC PDP). | 08-20-2009 |
| 20090261307 | Resistor Compositions using a Cu-containing Glass Frit - This invention relates to a composition using a ruthenium oxide and/or a polynary ruthenium oxide as conducting components and using a Cu containing glass frit. | 10-22-2009 |
| 20090298283 | CONDUCTIVE COMPOSITIONS AND PROCESSES FOR USE IN THE MANUFACTURE OF SEMICONDUCTOR DEVICES - ORGANIC MEDIUM COMPONENTS - Embodiments of the invention relate to a silicon semiconductor device, and a conductive paste for use in the front side of a solar cell device. | 12-03-2009 |
| 20100230646 | BLACK PIGMENT COMPOSITIONS, THICK FILM BLACK PIGMENT COMPOSITIONS, CONDUCTIVE SINGLE LAYER THICK FILM COMPOSITIONS, AND BLACK AND CONDUCTIVE ELECTRODES FORMED THEREFROM - The present invention is directed to pigment compositions with the formula Bi | 09-16-2010 |
| Patent application number | Description | Published |
|---|
| 20080213309 | MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS - Viral replicon selected nucleic acid expression libraries are useful for analyzing multiple antigens associated with a parasite, pathogen or neoplasia or for preparing immunogenic compositions for generating immune responses specific for the parasite, pathogen or neoplasia. Alphavirus replicon particles representative of the nucleic acid expression library are preferred. The nucleic acid library can be a random library, or it can be prepared after a selection step, for example, by differential hybridization prior to cloning into the replicon vector. | 09-04-2008 |
| 20090022760 | Alphavirus Replicon Particles Matched to Protein Antigens as Immunological Adjuvants - The immune response to an antigen of interest, especially one in purified form, can be significantly enhanced by the simultaneous administration of an alphavirus replicon particle which expresses the same antigen. This allows for the use of significantly smaller quantities of the protein antigen than in conventional immunization strategies, and this new immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen. | 01-22-2009 |
| 20090075384 | PROMOTERLESS CASSETTES FOR EXPRESSION OF ALPHAVIRUS STRUCTURAL PROTEINS - The present invention provides an isolated RNA molecule comprising: a) an alphavirus 5′ replication recognition sequence, wherein at least one initiation codon has been removed from the 5′ replication recognition sequence; b) a nucleotide sequence encoding an alphavirus structural protein; and c) an alphavirus 3′ replication recognition sequence, with the proviso that the RNA molecule does not contain a promoter that directs transcription of the nucleotide sequence of (b), and wherein the alphavirus 5′ and 3′ replication recognition sequences of (a) and (c) direct replication of the RNA molecule in the presence of alphavirus nonstructural proteins. | 03-19-2009 |
| 20100183665 | PROMOTERLESS CASSETTES FOR EXPRESSION OF ALPHA VIRUS STRUCTURAL PROTEINS - The present invention provides an isolated RNA molecule comprising: a) an alphavirus 5′ replication recognition sequence, wherein at least one initiation codon has been removed from the 5′ replication recognition sequence; b) a nucleotide sequence encoding an alphavirus structural protein; and c) an alphavirus 3′ replication recognition sequence, with the proviso that the RNA molecule does not contain a promoter that directs transcription of the nucleotide sequence of (b), and wherein the alphavirus 5′ and 3′ replication recognition sequences of (a) and (c) direct replication of the RNA molecule in the presence of alphavirus non-structural proteins. | 07-22-2010 |
| 20110027306 | TC-83-Derived Alphavirus Vectors, Particles and Methods - The present disclosure provides TC-83 VEE-derived replicons, alphaviral replicon particles and immunogenic compositions containing TC-83 alphaviral replicon particles which direct the expression of at least one antigen when introduced into a suitable host cell. The TC-83 VEE-derived ARPs described herein are improved in that they are subject to a lower vector-specific immune response than prior art ARPs. | 02-03-2011 |
| 20110086062 | ALPHAVIRUS REPLICON PARTICLES MATCHED TO PROTEIN ANTIGENS AS IMMUNOLOGICAL ADJUVANTS - The immune response to an antigen of interest, especially one in purified form, can be significantly enhanced by the simultaneous administration of an alphavirus replicon particle which expresses the same antigen. This allows for the use of significantly smaller quantities of the protein antigen than in conventional immunization strategies, and this new immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen. | 04-14-2011 |
